Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
Clinical trial NCT01981616 · COMPLETED
Trial details
- NCT number
- NCT01981616
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-05-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.